Golden Drugs Co., Inc. v. Maxwell-Jolly

179 Cal. App. 4th 1455, 102 Cal. Rptr. 3d 446, 2009 Cal. App. LEXIS 1977
CourtCalifornia Court of Appeal
DecidedDecember 9, 2009
DocketC058178
StatusPublished
Cited by15 cases

This text of 179 Cal. App. 4th 1455 (Golden Drugs Co., Inc. v. Maxwell-Jolly) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Golden Drugs Co., Inc. v. Maxwell-Jolly, 179 Cal. App. 4th 1455, 102 Cal. Rptr. 3d 446, 2009 Cal. App. LEXIS 1977 (Cal. Ct. App. 2009).

Opinion

Opinion

SIMS, J.

Golden Drugs Co., Inc., doing business as Golden Drugs Pharmacy (Pharmacy), appeals from a judgment denying its petition for a writ of mandamus (Code Civ. Proc., § 1085), which challenged the termination of Pharmacy’s Medi-Cal provisional provider license by defendant Sandra Shewry, as then director of the State Department of Health Care Services (the Department). (Health & Saf. Code, § 20 [name change from Department of Health Services]; Welf. & Inst. Code, § 14043.65. 1 ) Pharmacy *1458 disputes that it allowed a pharmacy technician to dispense medication without direct supervision and control of a pharmacist. Pharmacy contends (1) this court should consider extra-record evidence; (2) the evidence is insufficient to support the judgment; and (3) the Department’s actions were arbitrary and capricious and denied due process. We shall affirm the judgment.

STATUTORY AND REGULATORY FRAMEWORK

The Department administers the Medi-Cal program, by which California participates in the federal Medicaid program (42 U.S.C. § 1396 et seq.) to provide medical services to eligible persons. (§§ 10720 et seq., 14000 et seq.; Cal. Code Regs., tit. 22, § 51000 et seq.; Marvin Lieblein, Inc. v. Shewry (2006) 137 Cal.App.4th 700, 707 [40 Cal.Rptr.3d 547].)

To obtain reimbursement for services provided through Medi-Cal, a medical professional must enroll as a Medi-Cal “provider,” i.e., an entity that “provides services, goods, supplies, or merchandise” to Medi-Cal beneficiaries. (§ 14043.1, subd. (e).) In order to be a Medi-Cal provider, the medical professional must comply with Medi-Cal statutes and regulations, as well as statutes and regulations governing the provider’s profession. (§§ 14043.1, 14043.27. 2 )

The practice of pharmacy is a profession subject to the Pharmacy Law (Bus. & Prof. Code, §§ 400-4226, 4050). Pharmacies must be licensed by the California State Board of Pharmacy (the Board), which has as its “highest priority” the “[protection of the public.” (Bus. & Prof. Code, § 4001.1; see id., § 4110.) Every pharmacy must have a “pharmacist-in-charge” who is licensed by the Board and “responsible for a pharmacy’s *1459 compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.” (Bus. & Prof. Code, § 4113, subd. (b); see id., § 4036.) A pharmacist may be assisted by a “pharmacy technician,” who must be licensed as such and is “an individual who assists a pharmacist in a pharmacy in the performance of his or her pharmacy related duties, as specified in Section 4115.” (Bus. & Prof. Code, §§ 4115, subd. (e), 4038, subd. (a).)

Business and Professions Code section 4115 states in part:

“(a) A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks, only while assisting, and while under the direct supervision and control of a pharmacist.
“(b) This section does not authorize the performance of any tasks specified in subdivision (a) by a pharmacy technician without a pharmacist on duty.
“(c) This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
“(d) The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist.”

The Board adopted a regulation (Cal. Code Regs., tit. 16, § 1793.2 (regulation 1793.2)), stating, “ ‘Nondiscretionary tasks’ as used in Business and Professions Code section 4115, include: [|] (a) removing the drug or drugs from stock; [f] (b) counting, pouring, or mixing pharmaceuticals; [f] (c) placing the product into a container; [j[] (d) affixing the label or labels to the container; [and] [f] (e) packaging and repackaging.” Another regulation states that “[o]nly a pharmacist” (or an intern pharmacist acting under the pharmacist’s supervision) may interpret a prescription; “[supervise the packaging of drugs and check the packaging procedure and product upon completion”; and “[p]erform all functions which require professional judgment.” (Cal. Code Regs., tit. 16, § 1793.1 (regulation 1793.1).)

FACTUAL AND PROCEDURAL BACKGROUND

On February 3, 2006, the Department sent a letter to Pharmacy, located in Los Angeles, stating the Department was terminating Pharmacy’s Medi-Cal provisional provider status, effective on February 21, 2006, in accordance *1460 with section 14043.27 (see fn. 2, ante), because during a field audit, an auditor and consultant “directly observed the pharmacy technician dispensing medication intended for delivery to clients without direct supervision and control of a pharmacist. This violates California Business and Professions Code [section] 411 [sic: 4115] (a) and (f), which states in part: [1] ‘. . . a pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks, only while assisting, and while under the direct supervision and control of a pharmacist. . . . [T]he pharmacy technician shall be within the pharmacist’s view . . . ,” 3

On February 16, 2006, the Department sent Pharmacy an amended letter correcting the Medi-Cal provider number.

On February 22, 2006, Pharmacy’s attorney responded that there must be some mistake and requested an informal meeting to “obviate the expenditure of resources” on an administrative appeal.

As alleged in Pharmacy’s writ petition, Pharmacy’s attorney and its pharmacist-in-charge (PIC) Luther Jenkins met in Sacramento on March 22, 2006, with Jan Inglish, chief of the Department’s medical review branch, audits and investigations section, and members of her staff. Jenkins allegedly provided documents and live “testimony” contradicting the Department’s facts, and Inglish allegedly asked inappropriate questions about the ethnic makeup of the community where Pharmacy was located; the national origin of Pharmacy’s owners; and the relative salaries of the owners and pharmacist.

On May 25, 2006, the Department sent an “Amendment to Letter Dated February 16, 2006” to Luther Jenkins, president, chief executive officer and PIC of Golden Drugs Co., Inc. The letter stated the Department “is terminating your Medi-Cal provisional provider status, suspending you from enrollment and participation in the Medi-Cal program, and deactivating your provider number . . . [effective] June 14, 2006, in accordance with . . . [section] 14043.27 [fn. 2, ante].”

In addition to the facts asserted in the prior termination letter, the May 2006 letter said that it conducted an onsite review on November 28, 2005, which revealed (1) Pharmacy changed ownership in May 2003; (2) after the *1461

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Doe v. White CA2/6
California Court of Appeal, 2022
Brown v. Safeway CA1/5
California Court of Appeal, 2021
Ruegg & Ellsworth v. City of Berkeley
California Court of Appeal, 2021
Delta Stewardship Council Cases
California Court of Appeal, 2020
Great Oaks Water Co. v. Santa Clara Valley Water Dist.
196 Cal. Rptr. 3d 171 (California Court of Appeals, 6th District, 2015)
Great Oaks v. Santa Clara Valley Water Dist.
California Court of Appeal, 2015
Wallace v. Springall CA2/6
California Court of Appeal, 2013
Los Angeles International Charter High School v. Los Angeles Unified School District
209 Cal. App. 4th 1348 (California Court of Appeal, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
179 Cal. App. 4th 1455, 102 Cal. Rptr. 3d 446, 2009 Cal. App. LEXIS 1977, Counsel Stack Legal Research, https://law.counselstack.com/opinion/golden-drugs-co-inc-v-maxwell-jolly-calctapp-2009.